share_log

博安生物发布中期业绩 股东应占溢利6167.2万元同比扭亏为盈

Boan Biotechnology announced its interim results, with a shareholder's share of profit attributable to RMB 61.672 million, turning losses into profits year on year.

新浪港股 ·  Aug 28, 2024 08:26

Boan Biotech (06955) released its financial results for the six months ending on June 30, 2024, with a total revenue of 0.363 billion yuan (RMB) in the period, an increase of 38.93% year-on-year. The net profit attributable to the owners of the parent company was 61.672 million yuan, while in the same period last year, the net loss attributable to the owners of the parent company was 0.12 billion yuan. The basic earnings per share were 0.12 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment